Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
3(30%)
Results Posted
33%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(3)
Terminated(1)

Detailed Status

Recruiting3
Completed3
Enrolling by invitation2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (16.7%)
N/A5 (83.3%)

Trials by Status

enrolling_by_invitation220%
terminated110%
not_yet_recruiting110%
recruiting330%
completed330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
10